Measles mumps rubella ayurvedic and modern aspect

3. INTRODUCTION
• IT IS THE COMMONEST AND MOST
INFECTIOUS OF ALL THE VIRUSES OF
CHILDHOOD.
• IT IS THE FREQUENT CAUSE OF ILL
HEALTH AND MORBIDITY ESPECIALLY
IN THE UNDERNOURISHED INFANTS
AND CHILDREN BELOW THE AGE OF 3
YEARS.

4. EPIDEMIOLOGY
CAUSATIVE AGENT: MEASLES VIRUS OF
PARAMYXOVIRIDAE FAMILY
MODE OF TRANSMISSION: BY DIRECT
SPREAD FROM SECRETION OF NOSE AND
THROAD.
PERIOD OF INFECTIVITY: 4 DAYS PRIOR
TO AND 5 DAYS AFTER THE APPEARANCE
OF RASH.
INCIDENCE:HIGHEST IN WINTER AND
SPRING

5. PATHOLOGY
INFECT BY
INVASION OF
RESPIRATORY
EPITHELIUM
LOCAL
MULTIPLICATIO
N
VIREMIA
SPREAD TO
RETICULO-
ENDOTHELIAL
SYSTEM
SECONDARY
VIREMIA
SYSTEMIC
SYMPTOMS

6. CLINICAL FEATURES
INCUBATION PERIOD: 8-12 DAYS
PRODROMAL PHASE:
• MODERATE RISE IN TEMPERATURE
• COUGH
• RUNNING NOSE
• SNEEZING
• REDNESS OF EYES
• EXCESSIVE LACRIMATION

7. CLINICAL FEATURES
• KOPLIK’S SPOTS

8. CLINICAL FEATURES
ERUPTIVE PHASE:
• FEVER RISE AGAIN
RASH:
 1ST APPEAR BEHIND EARS, FOREHEAD, FACE,
NECK AND SPREAD TO TRUNK, EXTREMITIES,
PALMS AND SOLES.

9. DIAGNOSIS
• BASED ON CLINICAL
DIAGNOSIS
• SEROLOGICAL TESTS
FOR CONFIRMA-TION
• IgM ANTIBODIES.

10. PREVENTION & TREATMENT
• THERE IS NO SPECIFIC TREATMENT.
• ONLY SYMPTOMATIC AND SUPPORTIVE
TREATMENT IS DONE.
GIVE BATH TO CHILD DAILY
WASH MOUTH AND BRUSH TEETH DAILY
GIVE ADEQUATE FLUID

11. PREVENTION & TREATMENT
PROPHYLAXIS: ONLY RELIABLE
MEANS OF PREVENTING IS
ADMINISTRATION OF VACCINE MMR
1ST DOSE AT THE AGE OF 9-12 MONTHS
2ND DOSE AT THE AGE OF 15-18
MONTHS
0.5 ml SUBCUTANEOUSLY AT RIGHT
UPPER ARM

12. KARNAMOOLA SHOTHA

13. INTRODUCTION
THIS IS AN ACUTE VIRAL INFECTION
ALSO CALLED INFECTIOUS PAROTITIS
IT IS CHARACTERISED BY PAINFUL
SWELLING OF SALIVARY GLANDS
ESPECIALLY THE PAROTID AND
FREQUENTLY BY CNS INVOLVEMENT
THE MAJORITY OF SUFERERS (80%)
BELONG TO PEDIATRIC AGE GROUP
A SINGLE ATTACK LEADS TO LIFE LONG
IMMUNITY

14. EPIDEMIOLOGY
CAUSATIVE ORGANISM: MUMPS VIRUS
INCIDENCE:
• ENDEMIC WORLD OVER.
• MOST CASES OCCUR B/W 5 & 15 YEARS.
• INCIDENCE IS HIGHER IN WINTER &
SPRING

15. EPIDEMIOLOGY
TRANSMISSION:
• DIRECT CONTACT.
• AIRBORNE DROPLETS.
PERIOD OF INFECTIVITY: 7 DAYS PRIOR
TO AND 9 DAYS AFTER THE
APPEARANCE OF SWELLING.
INCUBATION PERIOD: 2 TO 4 WEEKS

16. CLINICAL FEATURES
 ONE THIRD PATIENTS ARE
ASYMPTOMATIC
 SYMPTOMS START WITH
FEVER
HEADACHE
NAUSEA
MALAISE
LOSS OF APETITE

17. CLINICAL FEATURES
SALIVARY MANIFESTATIONS:
• PAIN NEAR LOBE OF EAR AND DIFFICULTY IN
CHEWING
• PAROTID SWELLING
• ENLARGED PAROTID OBLITERATE MANDIBULAR
ANGLE
• OPENING OF STENSON DUCT APPEAR RED
• SUBMAXILLARY AND SUBLINGUAL GLANDS MAY
ALSO BE ENLARGED.

18. CLINICAL FEATURES
• SALIVARY MANIFESTATIONS

19. CLINICAL FEATURES
EXTRASALIVARY MANIFESTATION:
• ASEPTIC MENINGITIS
• SEVERE HEADACHE
• VOMITING
• NECK STIFFNESS

20. PROGNOSIS
PROGNOSIS IS EXCELLENT
THE DISEASE BEGINS
UNILATERALLY BUT
INVOLVES OTHER SIDE ALSO
WITHIN 48 TO 72 HRS IN 75%
FEVER AND TENDERNESS
SETTLE IN 1-6 DAYS
SWELLING DISAPPEARS IN 6-
10 DAYS.

21. DIAGNOSIS
BASED ON
CLINICAL
FEATURES
SERUM IgM
ELISA

22. PREVENTION & TREATMENT
 SYMPTOMATIC TREATMENT IS DONE
 PARACETAMOL AND ASPIRIN IS GIVEN
FOR PAIN
 WARM SALINE MOUTH WASHES
 CHILD SHOULD BE ISOLATED UNTIL
PAROTID SWELLING HAS RESOLVED
PROPHYLAXIS: ADMINISTRATION OF
MMR VACCINE
1ST DOSE AT THE AGE OF 9-12 MONTHS
2ND DOSE AT THE AGE OF 15-18
MONTHS

23. GERMAN MEASLES

24. INTRODUCTION
IT IS A LESS CONTAGIOUS VIRAL
DISEASE CHARACTERISED BY MILD
PRODRONAL SYMPTOMS, A TYPICAL
ERUPTION & ENLARGEMENT OF
CERVICAL LYMPH NODES.

25. INTRODUCTION
MOST PEOPLE WHO HAVE HAD RUBELLA
OR VACCINE ARE PROTECTED AGAINST
THE VIRUS FOR THE REST OF THEIR
LIVES
BECAUSE OF ROUTINE VACCINATION
AGAINST RUBELLA SINCE 1970, RUBELLA
IS NOW RARELY REPORTED

26. EPIDEMIOLOGY
CAUSATIVE ORGANISM: RUBELLA
VIRUS A ss-RNA TOGA VIRUS
MODE OF TRANSMISSION:
• DIRECT CONTACT
• DROPLET METHOD
PERIOD OF INFECTIVITY: 5 DAYS PRIOR
TO AND 4 DAYS AFTER THE
APPEARANCE OF RASH.

27. EPIDEMIOLOGY
INCIDENCE:
• OCCURS WORLDWIDE
• PEAK INCIDENCE IS IN EARLY
WINTER OR LATE SPRING
INCUBATION PERIOD:
14-21 DAYS
AVG. 16 DAYS

28. CLINICAL FEATURES
INCUBATION PERIOD: 14-21 DAYS
AVG. 16 DAYS
PRODROMAL PHASE:
• IT LAST FOR A FEW DAYS
• SLIGHT MALAISE
• TENDER POSTERIOR CERVICAL
LYMPHADENOPATHY.
THIS PHASE MAY BE ENTIRELY
ABSENT OR REMAIN UNNOTICED.

29. CLINICAL FEATURESRASH
1ST VISIBLE SIGN
IT IS MACULE WHICH SPREAD
FROM FACE TO TRUNK &
EXTREMITIES
MACULES LATER BLEND
ERUPTION DISAPPEAR BY 3RD DAY

30. CONGENITAL RUBELLA
SYNDROME
• INFANTS BORN TO RUBELLA INFECTED MOTHER, MAY
SUFFER FROM MULTIPLE CONGENITAL DEFECTS WHICH IS
CALLED CRS.
ITS SYMPTOMS ARE:
• GROWTH RETARDATION
• MENTAL RETARDATION
• CHD(PDA)
• DEAFNESS
• RETINAL LESIONS

31. DIAGNOSIS
• VIRAL ISOLATION
• SEROLOGICAL TESTS
NEUTRALISATION
COMPLIMENT FIXATION
HEMAGGLUTINATION INHIBITION
FLUORESCENT ANTIBODY STUDIES

32. PREVENTION & TREATMENT
• NO SPECIFIC TREATMENT
• TREAT COMPLICATIONS
PROPHYLAXIS: ONLY RELIABLE
MEANS OF PREVENTING IS
ADMINISTRATION OF VACCINE MMR
1ST DOSE AT THE AGE OF 9-12 MONTHS
2ND DOSE AT THE AGE OF 15-18
MONTHS
0.5 ml SUBCUTANEOUSLY AT RIGHT
UPPER ARM

34. INTRODUCTION
MEASLES IS GENERALLY CORRELATED
WITH ROMANTIKA.
ACHARYA CHARAKA HAS DESCRIBED IT
IN SHOTHA CHIKITSADHYAY.
ACHARYA MADHAVAKARA CALLED IT A
TYPE OF “MASURIKA” & DESCRIBED IT.
IT IS A KAPHA & PITTA DOSHA
DOMINANT DISEASE.

35. NIDANA
ACCORDING TO ACHARYA SUSHRUTA IT IS AN
UPSARGAJANYA VYADHI, SO ITS CAUSES ARE
SIMILAR TO THAT,,WHICH ARE:
 CONTACT WITH INFECTED PERSON’S BODY
PARTS.
EXPIRATION [NIH: SHWASA]
EATING, SITTING & SLEEPING TOGETHER.
SHARING CLOTHES & OTHER ARTICLES WITH
INFECTED PERSON

36. LAKSHANA
ACCORDING TO CHARAK SAMHITA CHIKITSA
STHANA 12/92 ITS SYMPTOMS ARE
SMALL RED RASHES ALL OVER THE BODY
(PIDAKA)
FEVER (JWARA)
BURNING SENSATION (DAHA)
EXCESSIVE THIRST (TRISHNA)
ITCHING (KANDU)
ANOREXIA (ARUCHI)
COMMON COLD (PRATISHYAY)

37. LAKSHANA
• REDNESS OF EYES (NETRA ROGA)
• DROWSINESS (TANDRA)
• TIREDNESS (KLAMA)
• DEPRESSION (AVSADA)
• DIARRHOEA (ATISARA)
• HEADACHE (SHIRA SHOOLA)
• PHOOPHOBIA (PRAKASHA
ASAHIYATA)
• EXCESSIVE WEAKNESS (DAURBALYA)

38. CHIKITSA
TRIBHUVANA KIRTI RASA:
1/4-1/2 TABLET WITH ADRAKHA RASA AND HONEY
PRAVALA PISHTI:
30-60 mg WITH HONEY
LAKSHMI NARAYANA RASA + GOROCHANA +
PRAVALA PISHTI IN EQUAL PARTS:
30-60 mg WITH HONEY OR PATOLADI KWATHA

39. SUBMITTED BY:
MANDEEP KAUR
ROLL NO 24
GAC Patiala
SUBMITTED TO:
DR.K.K.CHOPRA
DR.SHALINI
DR.ASHWINI RANA